Cancer BiologybioRxivPreprint
Circulating inflammatory ILC2s as a biomarker of gastric cancer progression
Ryan N. O’Keefe, Kiruthiga Raghunathan, Moritz F. Eissmann…·Michael Büchert
This study identifies circulating inflammatory ILC2s as a biomarker for gastric cancer progression, showing their association with disease severity and potential for early detection.